An Open-Label Study to Assess Safety

Inclusion Criteria

• •1. Healthy male or non-pregnant female aged ≥ 18 years with a clinical diagnosis of plaque psoriasis.
• •2. Definite clinical diagnosis of stable plaque psoriasis for at least 6 months.
• •3. Subjects must be in good health and free from any clinically significant disease, including but not limited to, conditions that may interfere with the evaluation of plaque psoriasis.